Serological and molecular investigation of human brucellosis in participants of Famenin brucellosis cohort study, Hamadan, Iran
Background and Objectives: Brucella is an intracellular pathogen that causes brucellosis in humans and animals. This study aimed to assess the results of brucellosis seroprevalence among participants of the Famenin brucellosis cohort with molecular investigation technique and determine Brucella-approved species.
Materials and Methods: Following the first phase of the Famenin brucellosis cohort in 2016 which investigated the seroprevalence of brucellosis among 2367 participants in Famenin city, a total of 575 people including all seropositive and some seronegative people were examined again by wright serological tests in 2019. The PCR assay was accomplished on all cases that have wright titers ≥ 1/20 for tracing Brucella DNA using BCSP31 target gene and IS711 locus.
Results: Out of 575 studied cases, 145 people had wright titers ≥ 1/20. The PCR reactions of these 145 blood samples were positive in 63/145 (43.44%) tested samples using primers (B4/B5) for Brucella genus detection. In the second PCR assay using specific-primers for Brucella abortus and Brucella melitensis, 18/63 (28.57%) of the samples were diagnosed as B. abortus, and 18/63 (28.57%) were diagnosed as B. melitensis.
Conclusion: In this study, using the selected specific genes for the diagnosis of Brucella in the genus and species levels, the PCR technique was evaluated as a promising method for the rapid and safe detection of brucellosis besides the serological test for more accurate detection of brucellosis especially in cases that are not definitive.
2. Yu WL, Nielsen K. Review of detection of Brucella spp. by polymerase chain reaction. Croat Med J 2010;51:306-313.
3. Smith JA. Brucella Lipopolysaccharide and pathogenicity: The core of the matter. Virulence 2018;9:379-382.
4. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol 2002;90:81-110.
5. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, Soleimani Amiri MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 2004;132:1109-1114.
6. Elfaki MG, Uz-Zaman T, Al-Hokail AA, Nakeeb SM. Detection of Brucella DNA in sera from patients with brucellosis by polymerase chain reaction. Diagn Microbiol Infect Dis 2005;53:1-7.
7. Scholz HC, Hubalek Z, Sedlácek I, Vergnaud G, Tomaso H, Al Dahouk S, et al. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol 2008;58:375-382.
8. Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 2011;9:833-845.
9. Almuneef M, Memish ZA. Persistence of Brucella antibodies after successful treatment of acute brucellosis in an area of endemicity. J Clin Microbiol 2002;40:2313.
10. Atluri VL, Xavier MN, de Jong MF, den Hartigh AB, Tsolis RM. Interactions of the human pathogenic Brucella species with their hosts. Annu Rev Microbiol 2011;65:523-541.
11. Gorvel JP. Brucella: a Mr "Hide" converted into Dr Jekyll. Microbes Infect 2008;10:1010-1013.
12. Keramat F, Karami M, Alikhani MY, Bashirian S, Moghimbeigi A, Hashemi SH, et al. Seroprevalence of Brucellosis among general population in Famenin city, western Iran in 2016: The Famenin Brucellosis cohort study. Arch Iran Med 2020;23:749-756.
13. Keramat F, Majzobi MM, Poorolajal J, Ghane ZZ, Adabi M. Seroprevalence of Brucellosis in human immunodeficiency virus infected patients in Hamadan, Iran. Osong Public Health Res Perspect 2017;8:282-288.
14. Mantur B, Parande A, Amarnath S, Patil G, Walvekar R, Desai A, et al. ELISA versus conventional methods of diagnosing endemic brucellosis. Am J Trop Med Hyg 2010;83:314-318.
15. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis 2007;7:775-786.
16. Garshasbi M, Ramazani A, Sorouri R, Javani S, Moradi S. Molecular detection of Brucella species in patients suspicious of Brucellosis from Zanjan, Iran. Braz J Microbiol 2014;45:533-538.
17. Bahmani N, Mirnejad R, Arabestani MR, Mohajerie P, Hashemi SH, Karami M, et al. Comparison of PCR-RFLP and PFGE for determining the clonality of Brucella isolates from human and livestock specimens. Saudi J Biol Sci 2019;26:256-262.
18. Navarro E, Casao MA, Solera J. Diagnosis of human brucellosis using PCR. Expert Rev Mol Diagn 2004;4:115-123.
19. Peeridogaheh H, Golmohammadi MG, Pourfarzi F. Evaluation of ELISA and Brucellacapt tests for diagnosis of human Brucellosis. Iran J Microbiol 2013;5:14-18.
20. Keramat F, Karami M, Alikhani MY, Bashirian S, Moghimbeigi A, Adabi M. Cohort profile: Famenin Brucellosis cohort study. J Res Health Sci 2019;19(3):e00453.
21. Dadar M, Alamian S, Behrozikhah AM, Yazdani F, Kalantari A, Etemadi A, et al. Molecular identification of Brucella species and biovars associated with animal and human infection in Iran. Vet Res Forum 2019;10:315-321.
22. Zerva L, Bourantas K, Mitka S, Kansouzidou A, Legakis NJ. Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J Clin Microbiol 2001;39:1661-1664.
23. El Kholy AA, Gomaa HE, El Anany MG, Abd El Rasheed E. Diagnosis of human brucellosis in Egypt by polymerase chain reaction. East Mediterr Health J 2009;15:1068-1074.
24. Gemechu MY, Gill JP, Arora AK, Ghatak S, Singh DK. Polymerase chain reaction (PCR) assay for rapid diagnosis and its role in prevention of human brucellosis in Punjab, India. Int J Prev Med 2011;2:170-177.
25. Sofian M, Safaeipour L, Aghakhani A, Sharif MR, Banifazl M, Sharif A, et al. Screening of family members of patients with acute brucellosis in an endemic area of Iran. Iran J Microbiol 2013;5:215-219.
|Issue||Vol 13 No 3 (2021)|
|Polymerase chain reaction; Serological test; Brucella abortus; Brucella melitensis; Brucellosis|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|